Crossmark

Heterogeneity of TP53 mutations necessitates differentiation with p53-rescue therapies

Published Online: 2025-05-16

Published Print: 2025-07

Authors

Wu, Jiaqi

Song, Huaxin

Xiao, Shujun

Lu, Min https://orcid.org/0000-0001-6902-3751
License Information

Text and Data Mining valid from 2025-05-16

Version of Record valid from 2025-05-16
More Information

Article History

First Online: 16 May 2025

Competing interests

: M.L. and H.S. are co-authors of the patents ‘PANDA as a novel therapeutic’ (PCT/CN2018/085190) and ‘mp53 rescue compounds and methods of treating a p53 disorder’ (PCT/CN2019/070117). J.W. and S.X. declare no competing interests.

Document is current